rs1721905984
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_005087.4(FXR1):c.346A>G(p.Asn116Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005087.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FXR1 | NM_005087.4 | c.346A>G | p.Asn116Asp | missense_variant | Exon 5 of 17 | ENST00000357559.9 | NP_005078.2 | |
FXR1 | NM_001013438.3 | c.346A>G | p.Asn116Asp | missense_variant | Exon 5 of 16 | NP_001013456.1 | ||
FXR1 | NM_001013439.3 | c.91A>G | p.Asn31Asp | missense_variant | Exon 6 of 18 | NP_001013457.1 | ||
FXR1 | NM_001363882.1 | c.91A>G | p.Asn31Asp | missense_variant | Exon 6 of 17 | NP_001350811.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Congenital myopathy Uncertain:1
The heterozygous p.Asn116Asp variant in FXR1 was identified by our study in 1 individual with congenital myopathy. Trio genome analysis showed this variant to be de novo. The variant has not been previously reported in individuals with congenital myopathy and was absent from large population studies. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. Finally, although this gene has been reported in association with congenital myopathy, it currently has limited evidence for these associations. In summary, while there is some suspicion for a pathogenic role, the evidence for this gene-disease relationship is limited and therefore the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PS2, PM2 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at